Although small case series evaluated the MGMT status prior to TMZ treatment in aggressive adenomas and pituitary carcinomas, a systematic evaluation of MGMT and MSH6 status in functioning pituitary macroadenomas has not been performed thus far. The gene discussed is MGMT; the disease is adenoma.